Christopher Fraser

Person

Arlington, MA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Tolerogenic synthetic nanocarriers for allergy therapy
- Patent number 11,779,641
- Issue date Oct 10, 2023
- Selecta Biosciences, Inc.
- Takashi Kei Kishimoto
- B82 - NANO-TECHNOLOGY
Information Patent Grant
Tolerogenic synthetic nanocarriers
- Patent number 11,717,569
- Issue date Aug 8, 2023
- Selecta Biosciences, Inc.
- Christopher Fraser
- B82 - NANO-TECHNOLOGY
Information Patent Grant
Tolerogenic synthetic nanocarriers for generating CD8+ regulatory T...
- Patent number 10,441,651
- Issue date Oct 15, 2019
- Selecta Biosciences, Inc.
- Takashi Kei Kishimoto
- B82 - NANO-TECHNOLOGY
Information Patent Grant
Tolerogenic synthetic nanocarriers for antigen-specific deletion of...
- Patent number 10,420,835
- Issue date Sep 24, 2019
- Selecta Biosciences, Inc.
- Christopher Fraser
- B82 - NANO-TECHNOLOGY
Information Patent Grant
Tolerogenic synthetic nanocarriers for generating CD8+ regulatory T...
- Patent number 10,004,802
- Issue date Jun 26, 2018
- Selecta Biosciences, Inc.
- Takashi Kei Kishimoto
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Tolerogenic synthetic nanocarriers for antigen-specific deletion of...
- Patent number 9,987,354
- Issue date Jun 5, 2018
- Selecta Biosciences, Inc.
- Christopher Fraser
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Tolerogenic synthetic nanocarriers to reduce immune responses to th...
- Patent number 9,295,718
- Issue date Mar 29, 2016
- Selecta Biosciences, Inc.
- Christopher Fraser
- B82 - NANO-TECHNOLOGY
Information Patent Grant
Tolerogenic synthetic nanocarriers to reduce cytotoxic T lymphocyte...
- Patent number 9,289,477
- Issue date Mar 22, 2016
- Selecta Biosciences, Inc.
- Christopher Fraser
- B82 - NANO-TECHNOLOGY
Information Patent Grant
Tolerogenic synthetic nanocarriers for allergy therapy
- Patent number 9,289,476
- Issue date Mar 22, 2016
- Selecta Biosciences, Inc.
- Takashi Kei Kishimoto
- B82 - NANO-TECHNOLOGY
Information Patent Grant
Tolerogenic synthetic nanocarriers
- Patent number 9,265,815
- Issue date Feb 23, 2016
- Selecta Biosciences, Inc.
- Christopher Fraser
- B82 - NANO-TECHNOLOGY
Information Patent Grant
Tango 240 nucleic acids and uses thereof
- Patent number 8,754,199
- Issue date Jun 17, 2014
- Millennium Pharmaceuticals, Inc.
- Christopher Fraser
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Immunostimulatory oligonucleotides
- Patent number 8,546,550
- Issue date Oct 1, 2013
- Selecta Biosciences, Inc.
- Grayson B. Lipford
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of identifying compounds that bind TANGO240
- Patent number 8,187,819
- Issue date May 29, 2012
- Millennium Pharmaceuticals, Inc.
- Christopher C. Fraser
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of modulating the activity of TANGO332
- Patent number 8,076,086
- Issue date Dec 13, 2011
- Millennium Pharmaceuticals, Inc.
- Susan J. Kirst
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
TANGO 240 nucleic acids and uses thereof
- Patent number 7,544,491
- Issue date Jun 9, 2009
- Millennium Pharmaceuticals, Inc.
- Christopher C. Fraser
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Tango 405 polypeptides and uses thereof
- Patent number 7,459,530
- Issue date Dec 2, 2008
- Millennium Pharmaceuticals, Inc.
- Christopher C. Fraser
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Screening methods using B7-H2 molecules, members of the B7 family
- Patent number 7,432,062
- Issue date Oct 7, 2008
- Millennium Pharmaceuticals, Inc.
- Anthony J. Coyle
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Tango 240 nucleic acids and uses thereof
- Patent number 7,285,398
- Issue date Oct 23, 2007
- Millennium Pharmaceuticals, Inc.
- Christopher C. Fraser
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Tango 240 polypeptides and uses thereof
- Patent number 7,282,209
- Issue date Oct 16, 2007
- Millennium Pharmaceuticals, Inc.
- Christopher C. Fraser
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Nucleic acids encoding TANGO405 and functional fragments and uses t...
- Patent number 7,160,694
- Issue date Jan 9, 2007
- Millennium Pharmaceuticals, Inc.
- Christopher C. Fraser
- A01 - AGRICULTURE FORESTRY ANIMAL HUSBANDRY HUNTING TRAPPING FISHING
Information Patent Grant
FAIL molecules and uses thereof
- Patent number 7,109,319
- Issue date Sep 19, 2006
- Millennium Pharmaceuticals, Inc.
- Christopher C. Fraser
- A01 - AGRICULTURE FORESTRY ANIMAL HUSBANDRY HUNTING TRAPPING FISHING
Information Patent Grant
Tango 243 polypeptides and uses thereof
- Patent number 7,083,793
- Issue date Aug 1, 2006
- Millennium Pharmaceuticals, Inc.
- Christopher C. Fraser
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Nucleic acids corresponding to TANGO 294 a gene encoding a lipase—l...
- Patent number 7,033,780
- Issue date Apr 25, 2006
- Millennium Pharmaceuticals, Inc.
- Sean A. McCarthy
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
TANGO 332 polypeptides
- Patent number 6,960,651
- Issue date Nov 1, 2005
- Millennium Pharmaceuticals, Inc.
- Susan J. Kirst
- A01 - AGRICULTURE FORESTRY ANIMAL HUSBANDRY HUNTING TRAPPING FISHING
Information Patent Grant
B7-H2 nucleic acids, members of the B7 family
- Patent number 6,635,750
- Issue date Oct 21, 2003
- Millennium Pharmaceuticals, Inc.
- Anthony J. Coyle
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
B7-H2 Polypeptides
- Patent number 6,630,575
- Issue date Oct 7, 2003
- Millennium Pharmaceuticals, Inc.
- Anthony J. Coyle
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
TOLEROGENIC SYNTHETIC NANOCARRIERS FOR ALLERGY THERAPY
- Publication number 20240261396
- Publication date Aug 8, 2024
- Selecta Biosciences, Inc.
- Takashi Kei Kishimoto
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TOLEROGENIC SYNTHETIC NANOCARRIERS
- Publication number 20240156955
- Publication date May 16, 2024
- Selecta Biosciences, Inc.
- Christopher Fraser
- B82 - NANO-TECHNOLOGY
Information Patent Application
TOLEROGENIC SYNTHETIC NANOCARRIERS TO REDUCE IMMUNE RESPONSES TO TH...
- Publication number 20230321225
- Publication date Oct 12, 2023
- Selecta Biosciences, Inc.
- Christopher Fraser
- B82 - NANO-TECHNOLOGY
Information Patent Application
TOLEROGENIC SYNTHETIC NANOCARRIERS TO REDUCE ANTIBODY RESPONSES
- Publication number 20230321224
- Publication date Oct 12, 2023
- Selecta Biosciences, Inc.
- Christopher Fraser
- B82 - NANO-TECHNOLOGY
Information Patent Application
TOLEROGENIC SYNTHETIC NANOCARRIERS FOR ALLERGY THERAPY
- Publication number 20230310593
- Publication date Oct 5, 2023
- Selecta Biosciences, Inc.
- Takashi Kei Kishimoto
- B82 - NANO-TECHNOLOGY
Information Patent Application
TOLEROGENIC SYNTHETIC NANOCARRIERS FOR GENERATING CD8+ REGULATORY T...
- Publication number 20200101155
- Publication date Apr 2, 2020
- Selecta Biosciences, Inc.
- Takashi Kei Kishimoto
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TOLEROGENIC SYNTHETIC NANOCARRIERS FOR ANTIGEN-SPECIFIC DELETION OF...
- Publication number 20200101154
- Publication date Apr 2, 2020
- Selecta Biosciences, Inc.
- Christopher Fraser
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TOLEROGENIC SYNTHETIC NANOCARRIERS FOR ALLERGY THERAPY
- Publication number 20160279234
- Publication date Sep 29, 2016
- Selecta Biosciences, Inc.
- TAKASHI KEI KISHIMOTO
- B82 - NANO-TECHNOLOGY
Information Patent Application
TOLEROGENIC SYNTHETIC NANOCARRIERS TO REDUCE IMMUNE RESPONSES TO TH...
- Publication number 20160256401
- Publication date Sep 8, 2016
- Selecta Biosciences, Inc.
- Christopher Fraser
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TOLEROGENIC SYNTHETIC NANOCARRIERS
- Publication number 20160243253
- Publication date Aug 25, 2016
- Selecta Biosciences, Inc.
- Christopher Fraser
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TOLEROGENIC SYNTHETIC NANOCARRIERS TO REDUCE IMMUNE RESPONSES TO TH...
- Publication number 20160220501
- Publication date Aug 4, 2016
- Selecta Biosciences, Inc.
- Christopher Fraser
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TOLEROGENIC SYNTHETIC NANOCARRIERS FOR GENERATING CD8+ REGULATORY T...
- Publication number 20160030555
- Publication date Feb 4, 2016
- Selecta Biosciences, Inc.
- Takashi Kei Kishimoto
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TOLEROGENIC SYNTHETIC NANOCARRIERS FOR ALLERGY THERAPY
- Publication number 20160030554
- Publication date Feb 4, 2016
- Selecta Biosciences, Inc.
- Takashi Kei Kishimoto
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TOLEROGENIC SYNTHETIC NANOCARRIERS TO REDUCE CYTOTOXIC T LYMPHOCYTE...
- Publication number 20160022650
- Publication date Jan 28, 2016
- Selecta Biosciences, Inc.
- Christopher Fraser
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TOLEROGENIC SYNTHETIC NANOCARRIERS TO REDUCE IMMUNE RESPONSES TO TH...
- Publication number 20150335762
- Publication date Nov 26, 2015
- Selecta Biosciences, Inc.
- Christopher Fraser
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TOLEROGENIC SYNTHETIC NANOCARRIERS
- Publication number 20150328333
- Publication date Nov 19, 2015
- Selecta Biosciences, Inc.
- Christopher Fraser
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TOLEROGENIC SYNTHETIC NANOCARRIERS TO REDUCE ANTIBODY RESPONSES
- Publication number 20150320728
- Publication date Nov 12, 2015
- Selecta Biosciences, Inc.
- Christopher Fraser
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TOLEROGENIC SYNTHETIC NANOCARRIERS FOR ANTIGEN-SPECIFIC DELETION OF...
- Publication number 20150320884
- Publication date Nov 12, 2015
- Selecta Biosciences, Inc.
- Christopher Fraser
- G01 - MEASURING TESTING
Information Patent Application
SECRETED PROTEINS AND USES THEREOF
- Publication number 20140296101
- Publication date Oct 2, 2014
- Millennium Pharmaceuticals, Inc.
- Christopher C. Fraser
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Novel Genes Encoding Proteins Having Prognostic, Diagnostic, Preven...
- Publication number 20140072968
- Publication date Mar 13, 2014
- Dana-Farber Cancer Institute, Inc.
- Douglas A. Holtzman
- G01 - MEASURING TESTING
Information Patent Application
SECRETED PROTEINS AND USES THEREOF
- Publication number 20130123122
- Publication date May 16, 2013
- Millennium Pharmaceuticals, Inc.
- Christopher C. Fraser
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMPOSITIONS AND METHODS FOR PRODUCING ANTIGEN-SPECIFIC INDUCED TOL...
- Publication number 20130059009
- Publication date Mar 7, 2013
- Selecta Biosciences, Inc.
- Takashi Kei Kishimoto
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
TOLEROGENIC SYNTHETIC NANOCARRIERS COUPLED TO CD1D-RESTRICTED ANTIG...
- Publication number 20120301510
- Publication date Nov 29, 2012
- Selecta Biosciences, Inc.
- Takashi Kei Kishimoto
- B82 - NANO-TECHNOLOGY
Information Patent Application
TOLEROGENIC SYNTHETIC NANOCARRIERS FOR ALLERGY THERAPY
- Publication number 20120294888
- Publication date Nov 22, 2012
- Selecta Biosciences, Inc.
- Takashi Kei Kishimoto
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TOLEROGENIC SYNTHETIC NANOCARRIERS TO REDUCE ANTIBODY RESPONSES
- Publication number 20120276157
- Publication date Nov 1, 2012
- Selecta Biosciences, Inc.
- Christopher Fraser
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TOLEROGENIC SYNTHETIC NANOCARRIERS
- Publication number 20120276159
- Publication date Nov 1, 2012
- Selecta Biosciences, Inc.
- Christopher Fraser
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TOLEROGENIC SYNTHETIC NANOCARRIERS TO REDUCE IMMUNE RESPONSES TO TH...
- Publication number 20120276109
- Publication date Nov 1, 2012
- Selecta Biosciences, Inc.
- Christopher Fraser
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TOLEROGENIC SYNTHETIC NANOCARRIERS FOR ANTIGEN-SPECIFIC DELETION OF...
- Publication number 20120276134
- Publication date Nov 1, 2012
- Selecta Biosciences, Inc.
- Christopher Fraser
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TOLEROGENIC SYNTHETIC NANOCARRIERS FOR GENERATING CD8+ REGULATORY T...
- Publication number 20120276155
- Publication date Nov 1, 2012
- Selecta Biosciences, Inc.
- Takashi Kei Kishimoto
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TOLEROGENIC SYNTHETIC NANOCARRIER COMPOSITIONS WITH TRANSPLANTABLE...
- Publication number 20120276156
- Publication date Nov 1, 2012
- Selecta Biosciences, Inc.
- Christopher Fraser
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Christopher Fraser

Person

Patents Grantslast 30 patents

Tolerogenic synthetic nanocarriers for allergy therapy

Tolerogenic synthetic nanocarriers

Tolerogenic synthetic nanocarriers for generating CD8+ regulatory T...

Tolerogenic synthetic nanocarriers for antigen-specific deletion of...

Tolerogenic synthetic nanocarriers for generating CD8+ regulatory T...

Tolerogenic synthetic nanocarriers for antigen-specific deletion of...

Tolerogenic synthetic nanocarriers to reduce immune responses to th...

Tolerogenic synthetic nanocarriers to reduce cytotoxic T lymphocyte...

Tolerogenic synthetic nanocarriers for allergy therapy

Tolerogenic synthetic nanocarriers

Tango 240 nucleic acids and uses thereof

Immunostimulatory oligonucleotides

Methods of identifying compounds that bind TANGO240

Methods of modulating the activity of TANGO332

TANGO 240 nucleic acids and uses thereof

Tango 405 polypeptides and uses thereof

Screening methods using B7-H2 molecules, members of the B7 family

Tango 240 nucleic acids and uses thereof

Tango 240 polypeptides and uses thereof

Nucleic acids encoding TANGO405 and functional fragments and uses t...

FAIL molecules and uses thereof

Tango 243 polypeptides and uses thereof

Nucleic acids corresponding to TANGO 294 a gene encoding a lipase—l...

TANGO 332 polypeptides

B7-H2 nucleic acids, members of the B7 family

B7-H2 Polypeptides

Patents Applicationslast 30 patents

TOLEROGENIC SYNTHETIC NANOCARRIERS FOR ALLERGY THERAPY

TOLEROGENIC SYNTHETIC NANOCARRIERS

TOLEROGENIC SYNTHETIC NANOCARRIERS TO REDUCE IMMUNE RESPONSES TO TH...

TOLEROGENIC SYNTHETIC NANOCARRIERS TO REDUCE ANTIBODY RESPONSES

TOLEROGENIC SYNTHETIC NANOCARRIERS FOR ALLERGY THERAPY

TOLEROGENIC SYNTHETIC NANOCARRIERS FOR GENERATING CD8+ REGULATORY T...

TOLEROGENIC SYNTHETIC NANOCARRIERS FOR ANTIGEN-SPECIFIC DELETION OF...

TOLEROGENIC SYNTHETIC NANOCARRIERS FOR ALLERGY THERAPY

TOLEROGENIC SYNTHETIC NANOCARRIERS TO REDUCE IMMUNE RESPONSES TO TH...

TOLEROGENIC SYNTHETIC NANOCARRIERS

TOLEROGENIC SYNTHETIC NANOCARRIERS TO REDUCE IMMUNE RESPONSES TO TH...

TOLEROGENIC SYNTHETIC NANOCARRIERS FOR GENERATING CD8+ REGULATORY T...

TOLEROGENIC SYNTHETIC NANOCARRIERS FOR ALLERGY THERAPY

TOLEROGENIC SYNTHETIC NANOCARRIERS TO REDUCE CYTOTOXIC T LYMPHOCYTE...

TOLEROGENIC SYNTHETIC NANOCARRIERS TO REDUCE IMMUNE RESPONSES TO TH...

TOLEROGENIC SYNTHETIC NANOCARRIERS

TOLEROGENIC SYNTHETIC NANOCARRIERS TO REDUCE ANTIBODY RESPONSES

TOLEROGENIC SYNTHETIC NANOCARRIERS FOR ANTIGEN-SPECIFIC DELETION OF...

SECRETED PROTEINS AND USES THEREOF

Novel Genes Encoding Proteins Having Prognostic, Diagnostic, Preven...

SECRETED PROTEINS AND USES THEREOF

COMPOSITIONS AND METHODS FOR PRODUCING ANTIGEN-SPECIFIC INDUCED TOL...

TOLEROGENIC SYNTHETIC NANOCARRIERS COUPLED TO CD1D-RESTRICTED ANTIG...

TOLEROGENIC SYNTHETIC NANOCARRIERS FOR ALLERGY THERAPY

TOLEROGENIC SYNTHETIC NANOCARRIERS TO REDUCE ANTIBODY RESPONSES

TOLEROGENIC SYNTHETIC NANOCARRIERS

TOLEROGENIC SYNTHETIC NANOCARRIERS TO REDUCE IMMUNE RESPONSES TO TH...

TOLEROGENIC SYNTHETIC NANOCARRIERS FOR ANTIGEN-SPECIFIC DELETION OF...

TOLEROGENIC SYNTHETIC NANOCARRIERS FOR GENERATING CD8+ REGULATORY T...

TOLEROGENIC SYNTHETIC NANOCARRIER COMPOSITIONS WITH TRANSPLANTABLE...